Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 4
1993 1
1994 2
1995 3
1996 2
1997 3
1998 2
1999 4
2000 2
2001 4
2003 4
2004 3
2005 2
2007 1
2009 2
2010 1
2011 3
2012 2
2013 2
2014 5
2015 7
2016 6
2017 4
2018 5
2019 3
2020 1
2021 5
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis.
Hanafin PO, Sermet-Gaudelus I, Griese M, Kappler M, Ellemunter H, Schwarz C, Wilson J, Tan M, Velkov T, Rao GG, Schneider-Futschik EK. Hanafin PO, et al. Among authors: ellemunter h. Front Pharmacol. 2021 Aug 2;12:577263. doi: 10.3389/fphar.2021.577263. eCollection 2021. Front Pharmacol. 2021. PMID: 34408649 Free PMC article.
Cystic fibrosis in Austria.
Frischer T, Eber E, Ellemunter H, Zacharasiewicz A, Kaluza I, Riedler J, Renner S. Frischer T, et al. Among authors: ellemunter h. Wien Klin Wochenschr. 2017 Aug;129(15-16):527-532. doi: 10.1007/s00508-017-1179-x. Epub 2017 Feb 24. Wien Klin Wochenschr. 2017. PMID: 28236043
Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid.
Mainz JG, Arnold C, Wittstock K, Hipler UC, Lehmann T, Zagoya C, Duckstein F, Ellemunter H, Hentschel J. Mainz JG, et al. Among authors: ellemunter h. Front Immunol. 2021 May 5;12:642180. doi: 10.3389/fimmu.2021.642180. eCollection 2021. Front Immunol. 2021. PMID: 34025651 Free PMC article. Clinical Trial.
ICln: a chloride channel paramount for cell volume regulation.
Gschwentner M, Susanna A, Schmarda A, Laich A, Nagl UO, Ellemunter H, Deetjen P, Frick J, Paulmichl M. Gschwentner M, et al. Among authors: ellemunter h. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 2):S98-101; discussion S105-6. J Allergy Clin Immunol. 1996. PMID: 8939183 Review.
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.
Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, Borghi M, Puccetti M, De Zuani M, Pucillo CE, Paolicelli G, Zelante T, Renauld JC, Bereshchenko O, Sportoletti P, Lucidi V, Russo MC, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Ricciotti G, Ellemunter H, Ratclif L, Talesa VN, Napolioni V, Romani L. Moretti S, et al. Among authors: ellemunter h. Nat Commun. 2017 Jan 16;8:14017. doi: 10.1038/ncomms14017. Nat Commun. 2017. PMID: 28090087 Free PMC article.
79 results